CITIUS ONCOLOGY, INC. - 10-Q Filing
Citius Oncology reported a net loss of $26.6 million for the three months ended March 31, 2026, compared to a net loss of $7.7 million in the same period last year. The company generated revenue of $1.7 million during this quarter but faced significant operating expenses totaling nearly $29.95 million. Over six months, it recorded a cumulative net loss of $32.14 million with total revenues of $5.6 million.
Tickers: $CTOR